On October 21, Abbott announced plans to split the nutrition business into an independent listed company, which is expected to be completed by the end of 2027. The spin-off will be carried out by allocating shares in the new company to Abbott's existing shareholders. After the transaction is completed, the shareholders will simultaneously hold shares in Abbott and New Nutrition. The new company is expected to have annual sales of approximately US$8.5 billion, approximately 16,000 employees and 14 production sites. After the spin-off, Abbott expects annual sales of approximately US$42 billion and will focus on medical devices, wearable health devices, diagnostic products, and mature pharmaceuticals businesses.
Zhitongcaijing · 2d ago
Share
Listen to the news
On October 21, Abbott announced plans to split the nutrition business into an independent listed company, which is expected to be completed by the end of 2027. The spin-off will be carried out by allocating shares in the new company to Abbott's existing shareholders. After the transaction is completed, the shareholders will simultaneously hold shares in Abbott and New Nutrition. The new company is expected to have annual sales of approximately US$8.5 billion, approximately 16,000 employees and 14 production sites. After the spin-off, Abbott expects annual sales of approximately US$42 billion and will focus on medical devices, wearable health devices, diagnostic products, and mature pharmaceuticals businesses.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending